Guardian Pharmacy Services, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company headquartered in Nashville, Tennessee, primarily operating across 38 states in the United States. Founded to serve older adults and individuals with complex care needs, the company offers a comprehensive suite of technology-enabled pharmacy services including medication dispensing; clinical pharmacy services; medication management and adherence solutions; smart packaging; robotic dispensing; data analytics through its GuardianShield platform; and personalized pharmacy care tailored to assisted living facilities, behavioral health, post-acute care, hospice, and community care providers. Guardian Pharmacy operates a network of more than 53 pharmacies nationally, serving over 204,000 residents across approximately 8,200 long-term care facilities. Recent major developments include a strategic expansion through acquisitions and new pharmacy launches in 2024 and 2025. The company acquired Heartland Pharmacy in April 2024, Freedom Pharmacy in November 2024, Senior Care Pharmacy in Wichita, Kansas, and Managed Healthcare Pharmacy in Oregon, marking its first presence in the Pacific Northwest. It also opened a new greenfield pharmacy in Naples, Florida, enhancing its geographic footprint and service capabilities. These acquisitions and openings contributed to a 15% year-over-year increase in resident count to approximately 204,000 as of September 2025. Guardian Pharmacy Services also filed a Form S-3 shelf registration in 2025 for potential future capital raises and completed a non-dilutive secondary offering to enhance trading liquidity. The company reported strong financial performance in 2025, raising full-year guidance with revenue projected between $1.43 billion and $1.45 billion and Adjusted EBITDA between $104 million and $106 million. Guardian Pharmacy Services maintains a business model that emphasizes local management of pharmacies supported by a national corporate team, enabling high-touch, personalized care while leveraging advanced technology for operational efficiency and improved clinical outcomes. The company aims to improve medication adherence, reduce hospitalizations, and lower healthcare costs through its integrated pharmacy services. Its client base includes long-term care facilities, senior living communities, and providers supporting intellectually and developmentally disabled individuals, positioning Guardian as a leading LTC pharmacy services provider in the U.S. market. The company continues to pursue growth through acquisitions, operational expansion, and innovative pharmacy services enhancements.
Company News
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Moderate Buy” by Analysts
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services, Inc. $GRDN Shares Purchased by Bank of America Corp DE
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Guardian Pharmacy Services Q2 Earnings Call Highlights
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
First Trust Advisors LP Purchases Shares of 93,677 Guardian Pharmacy Services, Inc. $GRDN
Arrowstreet Capital Limited Partnership Buys 16,866 Shares of Guardian Pharmacy Services, Inc. $GRDN
Bessemer Group Inc. Purchases Shares of 78,656 Guardian Pharmacy Services, Inc. $GRDN
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
Guardian Pharmacy Services, Inc. Announces Leadership Transitions
Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Guardian Pharmacy Services Q1 Earnings Call Highlights
Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript